Altis has commercialized a patented stem cell platform, recreating the human intestinal barrier for pre-clinical drug development. The platform is currently used by 80% of top 20 pharma companies to reduce the cost and time of drug discovery by producing more accurate and reproducible data for better clinical trial performance.
Ready to Ask For Funding for your company?
Post a Funding Request